WEC
50
-5
FOX
59
2
ETN
79
-5
ED
43
-2
INTC
39
-10
SPG
60
-3
VMC
59
-4
UPS
48
-2
EXR
55
-4
GS
69
-6
AAL
59
2
DGX
39
-9
ORLY
66
-3
XYL
39
-2
JBHT
60
-3
IR
68
-3
HST
43
-7
NAVI
55
-2
LMT
34
-5
BMY
63
2
WEC
50
-5
FOX
59
2
ETN
79
-5
ED
43
-2
INTC
39
-10
SPG
60
-3
VMC
59
-4
UPS
48
-2
EXR
55
-4
GS
69
-6
AAL
59
2
DGX
39
-9
ORLY
66
-3
XYL
39
-2
JBHT
60
-3
IR
68
-3
HST
43
-7
NAVI
55
-2
LMT
34
-5
BMY
63
2
Financhill
Back

Bioage Labs 10K Form

Sell
41

BIOA
Bioage Labs

Last Price:
19.40
Seasonality Move:
--

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive BIOA News And Ratings

See the #1 stock for the next 7 days that we like better than BIOA

BIOA Financial Statistics

Sales & Book Value

Annual Sales: $14.94M
Cash Flow: $-15.82M
Price / Cash Flow: 0
Annual Sales: $-6.38
Price / Book: 0

Profitability

EPS (TTM): -1.77420
Net Income (TTM): $-54.84M
Gross Margin: $-7.38M
Return on Equity: 0%
Return on Assets: 0%

Bioage Labs Earnings Forecast

Key Bioage Labs Financial Ratios

  • The Gross Profit Margin over the past 5 years for BIOA is -49.40%.
  • The Selling, General & Administrative Expenses for BIOA have been equal to 95.65% of Gross Profit Margin.
  • The Interest Expense is -12.21% of Operating Income.
  • Per Share Earnings over the last 7 years have been positive in 3 years.

Bioage Labs Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Pharmaceuticals
Sector: Health Care
Current Symbol: BIOA
CUSIP: 09072Q
Website: bioagelabs.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 0
Quick Ratio: 0

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

BIOA Technical Analysis vs Fundamental Analysis

Sell
41
Bioage Labs (BIOA) is a Sell

Is Bioage Labs a Buy or a Sell?

  • Bioage Labs stock is rated a Sell
    The current Bioage Labs [BIOA] share price is $19.51. The Score for BIOA is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.